BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

11 articles for FM Ferguson

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
20
Discovery of a Series of 5,11-Dihydro-6EBI
Dana-Farber Cancer Institute
20
Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma.EBI
Harvard Medical School
38
Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6EBI
Harvard Medical School
91
Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.EBI
Harvard Medical School
25
Discovery and Structure-Activity Relationship Study of (EBI
Dana-Farber Cancer Institute
20
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.EBI
Dana-Farber Cancer Institute
33
Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.EBI
Dana Farber Cancer Institute
32
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.EBI
University of Cambridge
3
Characterization of a highly selective inhibitor of the Aurora kinases.EBI
Harvard Medical School
44
OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28BDB
Carmot Therapeutics
35
Fused piperidinyl bicyclic and related compounds as modulators of C5A receptorBDB
Inflarx